Syngene International News: Read Latest News & Live Updates on Syngene International, Photos, Videos at CNBCTV18.com

homeSyngene International News

Syngene International NEWS

All

market | Apr 24, 2024 8:55 PM IST
Syngene International Q4 | Profit up 6%, company to pay dividend of ₹1.25 per share
earnings | Jan 25, 2024 3:35 PM IST
Syngene Q3 results: Biocon unit cuts FY24 revenue growth guidance
market | Jan 16, 2024 11:55 AM IST
Syngene International shares drop 3% as UBS downgrades stock to ‘sell’
market | Oct 18, 2023 10:38 AM IST
Syngene International shares drop the most since 2019 after cutting full year growth guidance
healthcare | Oct 18, 2023 8:53 AM IST
Leaders Speak | How to transform India's pharma CDMO space through efficiency
market | Jul 27, 2023 10:58 PM IST
Syngene International shares hit record high after Q1 results; co on track to achieve FY24 guidance
market | Jul 26, 2023 5:03 PM IST
Syngene International Q1 profit jumps 26% to Rs 93 crore; revenue rises 25%
business | Jul 5, 2023 12:36 PM IST
Strides Pharma shares drop 7% after its biologics arm sells manufacturing facility to Syngene
business | Jun 12, 2023 8:13 PM IST
Syngene International outgrows its parent Biocon in market cap
business | Apr 27, 2023 11:44 AM IST
Syngene shares hit 52-week high after company surpasses FY23 guidance
business | Feb 10, 2023 5:58 PM IST
Biocon will pay off short-term loans worth $270 million using proceeds from Syngene stake sale
market | Jan 24, 2023 12:08 PM IST
Shares of Biocon's research arm drop after December quarter revenue growth misses estimates
healthcare | Jan 10, 2023 4:54 PM IST
Axis Capital positive on Syngene International, upgrades it to 'add'
earnings | Oct 20, 2022 4:07 PM IST
Syngene International says US dollar strength aided better-than-expected revenue growth
business | Oct 19, 2022 4:17 PM IST
Syngene climbs over 8% after better than expected September quarter

Syngene International NEWS

Syngene International Q4 | Profit up 6%, company to pay dividend of ₹1.25 per share

Syngene Q3 results: Biocon unit cuts FY24 revenue growth guidance

Syngene International shares drop 3% as UBS downgrades stock to ‘sell’

Syngene International shares drop the most since 2019 after cutting full year growth guidance

Leaders Speak | How to transform India's pharma CDMO space through efficiency

Syngene International shares hit record high after Q1 results; co on track to achieve FY24 guidance

Syngene International Q1 profit jumps 26% to Rs 93 crore; revenue rises 25%

Strides Pharma shares drop 7% after its biologics arm sells manufacturing facility to Syngene

Syngene International outgrows its parent Biocon in market cap

Syngene shares hit 52-week high after company surpasses FY23 guidance

Biocon will pay off short-term loans worth $270 million using proceeds from Syngene stake sale

Shares of Biocon's research arm drop after December quarter revenue growth misses estimates

Axis Capital positive on Syngene International, upgrades it to 'add'

Syngene International says US dollar strength aided better-than-expected revenue growth

Syngene climbs over 8% after better than expected September quarter